NEW YORK, May 28 (GenomeWeb News) - NewCap Partners, a Los Angeles-based boutique investment-banking company, is helping Shanghai Genomics forge contract research alliances with US drug makers, according to a report on Forbes.com today.
Shanghai Genomics, based in Shanghai, China,offers the following services, according to its website: siRNA design and synthesis; protein-protein interaction screening; and gene-expression studies using Q-PCR or IHC. The firm employs 70 person people.